Overall Survival in Heart Disease –Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study
This study highlights that NSCLC patients should be highly monitored during immunotherapy administration, and further assessment is needed.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Epidemiology | Heart | Heart Disease | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma | Study